Loss Aversion and Cost Effectiveness of Healthcare Programmes: Whose Aversion Counts Anyway?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.11, 2008-01, pp. : 899-900

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loss Aversion and Cost Effectiveness of Healthcare Programmes

By Gandjour Afschin

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 895-898

Adis International

Access to resources Recommend Favorite

Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?

By Bala M.V.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 495-498

Adis International

Access to resources Recommend Favorite

Considering loss aversion in economic evaluations

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 565, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cost effectiveness of adjuvant chemotherapy a generation game?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cost effectiveness of risperidone: is compliance the key?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite